Brii Biosciences Limited

Greenhouse gas emissions & sustainability report data

📊 Latest report period: 2023🗂️ Report periods on file: 2023, 2021

In its 2023 reporting, Brii Biosciences Limited disclosed greenhouse gas emissions of 68.67 tCO2e/year (Scope 2). By scope: Scope 1: 0 tCO2e/year; Scope 2: 68.67 tCO2e/year. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.

💨
GHG Emissions
68.67 tCO2e/year (Scope 2)
2023
💧
Water Usage
1.5K m3/year
2023
♻️
Waste
22.83 tons/year
2023
⚙️
Energy Use
120.41 MWh/year
2023

📊 Emissions by Scope (2023)

ScopeWhat it coversReported value
Scope 1Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions).0 tCO2e/year
Scope 2Indirect emissions from purchased electricity, steam, heat and cooling.68.67 tCO2e/year

New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.

📈 Emissions by Report Period

Report periodHeadline emissions figure reported
202368.67 tCO2e/year (Scope 2)
2021125.64 tons of carbon dioxide (Scope 2)

Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.

✅ Reported Environmental Achievements

🎯 Climate & Sustainability Targets

🔜 Short-term

  • Reduce electricity consumption
  • Improve water efficiency
  • Enhance waste management

🔭 Long-term

  • Achieve net-zero emissions (aligned with China's 2060 target)

🌱 ESG Focus Areas

Environmental SustainabilitySocial ResponsibilityGovernance

⚠️ Challenges & Risks +

  • Low awareness of HBV functional cure among Chinese patients
  • Need to improve access to PPD treatment
  • Managing climate-related risks

📋 Report Information

Reporting Period: 2023
Frameworks: HKEX ESG Reporting Guide, SASB Standards, Biopharma investor ESG communications guidance 4.0